1-13 of 13
Eleonora Russo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LONG-TERM Outcome of a Fondazione Italiana Linfomi Study Comparing Short Rituximab Maintenance Vs Observation after Brief First-LINE R-FND Chemoimmunotherapy Followed By Rituximab Consolidation in Elderly Patients with Advanced Follicular Lymphoma (FL)

Carola Boccomini, MD, Marco Ladetto, MD, Francesca Dutto, Simone Ferrero, MD, Luca Baldini, MD, Chiara Bottelli, MD, Claudia Castellino, MD, Annalisa Chiarenza, MD, Annarita Conconi, MD, Federico De Angelis, MD, Andrea Evangelista, Stefan Hohaus, MD, Francesco Merli, MD, Benedetta Puccini, MD, Chiara Rusconi, MD, Eleonora Russo, MD, Stefano Sacchi, MD, Stefano Volpetti, MD, Giuseppe Rossi, MD, Umberto Vitolo, MD
Journal: Blood
Blood (2015) 126 (23): 3985.
https://doi.org/10.1182/blood.V126.23.3985.3985
Published: 2015
Journal Articles

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Clinical Trials & Observations
Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J. M. Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini, Francesco Merli, Graziella Pinotti, Donato Mannina, Stefano Luminari, Anastasios Stathis, Eleonora Russo, Franco Cavalli, Luca Giovanella, Peter W. M. Johnson, Emanuele Zucca
Journal: Blood
Blood (2015) 126 (8): 950–956.
https://doi.org/10.1182/blood-2014-12-616474
Published: 2015
Includes: Supplemental data
Journal Articles

Peripheral T-Cell Lymphomas (PTCL) Treated With Or Without Upfront Autologous Stem Cell Transplantation: Results Of a Retrospective Single Center Analysis

Alice Di Rocco, MD, Angelo Fama, MD, Eleonora Russo, MD, Giovanna Meloni, MD, Paolo Paesano, MD, Laura Cesini, MD, Michela Ansuinelli, MD, Saveria Capria, MD, Maurizio Martelli, MD, Robin Foá, MD
Journal: Blood
Blood (2013) 122 (21): 5548.
https://doi.org/10.1182/blood.V122.21.5548.5548
Published: 2013
Journal Articles

Impact Of Bone Marrow Involvement On Outcome Of Young Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL) Treated In The Phase III Randomized Trial (DLCL04) With Rituximab Dose-Dense Chemotherapy Followed By Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Or Standard Rituximab Dose Dense Chemotherapy: A Study of The Fondazione Italiana Linfomi (FIL)

Umberto Vitolo, MD, Annalisa Chiappella, Ercole Brusamolino, Emanuele Angelucci, Giuseppe Rossi, Angelo Michele Carella, Andrea Evangelista, Caterina Stelitano, Monica Balzarotti, Francesco Merli, Gianluca Gaidano, Manuel Gotti, Vincenzo Pavone, Luigi Rigacci, Francesco Zaja, Chiara Rusconi, MD, Amalia De Renzo, Graziella Pinotti, Michele Pizzuti, Michele Spina, Maria Cantonetti, Giorgina Specchia, Patrizia Pregno, MD, Eleonora Russo, MD, Alessandra Tucci, Maria Giuseppina Cabras, Stefano A Pileri, Alessandro Levis, Maurizio Martelli, MD
Journal: Blood
Blood (2013) 122 (21): 4340.
https://doi.org/10.1182/blood.V122.21.4340.4340
Published: 2013
Journal Articles

Efficacy and Safety Of Melphalan and Prednisone In Combination With Thalidomide, Bortezomib Or Lenalidomide In Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients: A Single Center Experience

Fabiana Gentilini, MD, Vincenzo Federico, MD, Eleonora Russo, MD, Paola Finsinger, MD, Roberto Ricci, Patrizia Del Bianco, Francesca Prestanicola, Moira Cappelloni, Maria Letizia Vallone, Robin Foa, MD, Maria Teresa Petrucci, MD
Journal: Blood
Blood (2013) 122 (21): 5375.
https://doi.org/10.1182/blood.V122.21.5375.5375
Published: 2013
Journal Articles

Rituximab Dose-Dense Chemotherapy Followed by Intensified High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDC+ASCT) Significantly Reduces the Risk of Progression Compared to Standard Rituximab Dose-Dense Chemotherapy As First Line Treatment in Young Patients with High-Risk (aa-IPI 2–3) Diffuse Large B-Cell Lymphoma (DLBCL): Final Results of Phase III Randomized Trial DLCL04 of the Fondazione Italiana Linfomi (FIL)

Umberto Vitolo, Annalisa Chiappella, Ercole Brusamolino, Emanuele Angelucci, MD, Giuseppe Rossi, Angelo Michele Carella, Andrea Evangelista, Caterina Stelitano, Monica Balzarotti, Francesco Merli, Gianluca Gaidano, MD, PhD, Vincenzo Pavone, Luigi Rigacci, MD, Francesco Zaja, MD, Nicola Cascavilla, Alfonso Maria D'Arco, Chiara Rusconi, Amalia De Renzo, Graziella Pinotti, MD, Michele Spina, Patrizia Pregno, Eleonora Russo, MD, PhD, Manuel Gotti, Alessandra Tucci, Maria Giuseppina Cabras, MD, Stefano A. Pileri, MD, Alessandro Levis, MD, Maurizio Martelli, MD
Journal: Blood
Blood (2012) 120 (21): 688.
https://doi.org/10.1182/blood.V120.21.688.688
Published: 2012
Journal Articles

Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) for Newly Diagnosed Multiple Myeloma (MM) Patients

Antonio Palumbo, MD, Sara Bringhen, Oreste Villani, Agostina Siniscalchi, MD, Eleonora Russo, MD, PhD, Giuseppina Uccello, MD, Chiara Cerrato, MD, Milena Gilestro, Davide Rossi, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 730.
https://doi.org/10.1182/blood.V120.21.730.730
Published: 2012
Journal Articles

Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL)

Umberto Vitolo, MD, Marco Ladetto, Carola Boccomini, MD, Andrea Evangelista, Enrica Gamba, Eleonora Russo, Alessandra Tucci, Annalisa Chiarenza, Antonello Pinto, Amalia De Renzo, Francesco Zaja, Andrea Gallamini, MD, Alessia Bari, Isabel Alvarez, Elisa Bernocco, Mario Petrini, Guido Parvis, Benedetta Puccini, Paolo Corradini, Tommasina Perrone, Sharon Supekar, Annalisa Chiappella, Barbara Botto, MD, Barbara Mantoan, Federico De Angelis, Luca Baldini, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2011) 118 (21): 777.
https://doi.org/10.1182/blood.V118.21.777.777
Published: 2011
Journal Articles

Weekly Infusion of Bortezomib In Combination with Rituximab In Relapsed/Refractory Indolent Non-Follicular and Mantle Cell Lymphoma Is Safe and Effective: Two-Years Analysis of Phase II Trial BRIL06 of Intergruppo Italiano Linfomi (IIL)

Annalisa Chiappella, Patrizia Pregno, Pier Luigi Zinzani, Andrea Evangelista, Alberto Fabbri, Fabio Facchetti, Andres JM Ferreri, Silvia Franceschetti, Roberto Freilone, Livio Gargantini, Daniela Gioia, Anna Marina Liberati, Maura Nicolosi, Lorella Orsucci, Luigi Rigacci, Eleonora Russo, Vittorio Stefoni, Alessandra Tucci, Umberto Vitolo
Journal: Blood
Blood (2010) 116 (21): 3965.
https://doi.org/10.1182/blood.V116.21.3965.3965
Published: 2010
Journal Articles

Rituximab (R) Maintenance Versus Observation After Short Term Chemoimmunotherapy R-FND as First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Updated Results and Safety of the Maintenance of An Intergruppo Italiano Linfomi (IIL) Randomized Trial.

Umberto Vitolo, Carola Boccomini, Marco Ladetto, Enrica Gamba, Isabel Alvarez, Luca Baldini, Annalisa Chiappella, Annalisa Chiarenza, Paolo Corradini, Amalia De Renzo, Andrea Evangelista, Andrea Gallamini, Attilio Guarini, Stefan Hohaus, Anna Marina Liberati, Barbara Mantoan, Lorella Orsucci, Guido Parvis, Mario Petrini, Antonello Pinto, Enrico Pogliani, Samantha Pozzi, Alessandro Pulsoni, Luigi Rigacci, Eleonora Russo, Corrado Tarella, Alessandra Tucci, Francesco Zaja, Eugenio Gallo
Journal: Blood
Blood (2009) 114 (22): 1706.
https://doi.org/10.1182/blood.V114.22.1706.1706
Published: 2009
Journal Articles

The Combination of Bortezomib and Rituximab Is Effective and Safe in Relapsed/Refractory Indolent Non Follicular and Mantle-Cell Non Hodgkin Lymphoma: a Phase II Multicenter Study by Intergruppo Italiano Linfomi.

Annalisa Chiappella, Patrizia Pregno, Pier Luigi Zinzani, Fabio Facchetti, Andrea Evangelista, Alberto Fabbri, Andres JM Ferreri, Silvia Franceschetti, Roberto Freilone, Livio Gargantini, Daniela Gioia, Anna Marina Liberati, Lorella Orsucci, Luigi Rigacci, Eleonora Russo, Vittorio Stefoni, Alessandra Tucci, Umberto Vitolo
Journal: Blood
Blood (2009) 114 (22): 3758.
https://doi.org/10.1182/blood.V114.22.3758.3758
Published: 2009
Journal Articles

Increased Risk of Thrombotic Events in Patients with Acute Promyelocytic Leukemia (APL) Receiving ATRA Treatment: Does It Correlate with CD2 and FLT3 Expression?.

Massimo Breccia, MD, Roberto Latagliata, MD, Ida Carmosino, MD, Eleonora Russo, MD, Mariella D’Andrea, MD, Erica Finolezzi, MD, Nicol Iorio, MD, Cinzia Fazio, MD, Giuseppe Avvisati, PhD, Maria Concetta Petti, PhD, Francesco Lo-Coco, PhD, Franco Mandelli, PhD
Journal: Blood
Blood (2005) 106 (11): 887.
https://doi.org/10.1182/blood.V106.11.887.887
Published: 2005
Journal Articles

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Roberto Latagliata, MD, Massimo Breccia, MD, Ida Carmosino, MD, Chiara Sarlo, MD, Rosa De Cuia, MD, Marco Mancini, MD, Francesca Biondo, MD, Eleonora Russo, MD, Annalisa De Vellis, MD, Daniela Diverio, MD, Franco Mandelli, PhD, Giuliana Alimena, PhD
Journal: Blood
Blood (2004) 104 (11): 4693.
https://doi.org/10.1182/blood.V104.11.4693.4693
Published: 2004